MC
CEMI

Moors & Cabot’s Chembio diagnostics, Inc. CEMI Stock Holding History

Moors & Cabot’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-33,509
Closed -$201K – 572
2016
Q1 		$201K Sell
33,509
-19,300
-37% -$99.6K 0.04% 452
2015
Q4 		$281K Sell
52,809
-1,384
-3% -$6.94K 0.05% 367
2015
Q3 		$218K Hold
54,193
– – 0.04% 437
2015
Q2 		$266K Hold
54,193
– – 0.04% 417
2015
Q1 		$219K Hold
54,193
– – 0.04% 446
2014
Q4 		$212K Buy
+54,193
New +$224K 0.04% 441

Other funds holding CEMI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCCM
Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Moors & Cabot's CEMI Position: Q2 2016 in Review

Moors & Cabot sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2016, closing a stake of 33,509 shares — an estimated $201K sold.

Moors & Cabot first reported a position in CEMI in Q4 2014 and held it in 6 quarters. The position peaked at $281K in Q4 2015. 26 funds tracked by Wall St. Rank hold CEMI as of Q2 2016.

  • Moors & Cabot reported no remaining Chembio diagnostics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Moors & Cabot sold 33,509 Chembio diagnostics, Inc. shares in Q2 2016, an estimated $201K.
  • Moors & Cabot first reported a position in Chembio diagnostics, Inc. in Q4 2014 and held it in 6 quarters.
  • Moors & Cabot's Chembio diagnostics, Inc. position peaked at $281K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2016.

Based on Moors & Cabot's 13F filing for Q2 2016, filed 8 Aug 2016.